Inmed to present at virtual conferences in march 2021

Vancouver, british columbia, march 03, 2021 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm; tsx:in), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates targeting diseases with high unmet medical need and leading the clinical development of cannabinol (“cbn”), today announced that eric a. adams, president and ceo of inmed, will be presenting at investor conferences in march 2021. the details of each conference are included below.
INM Ratings Summary
INM Quant Ranking